Company Overview

Avisa Pharma Advanced Research Centre, founded in March 2023, is a research-driven pharmaceutical company in the pharmaceutical domain. Established by Dr. Rajesh Pawar, a seasoned technocrat with approximately three decades of industry expertise, the company boasts a dedicated R&D team comprising highly skilled professionals.

From its inception, Avisa Pharma has maintained a vertical integration approach, emphasizing the production of active pharmaceutical ingredients, peptides, semi-synthetics, and synthetics. The company focuses on Cephalosporins, Carbapenems, Anti-inflammatory drugs, Antihypertensive & Cardiovascular products based on in-house developed actives. Avisa Pharma has successfully commercialized numerous actives from its in-house Kg manufacturing units and has fostered collaborations with various contract manufacturing organizations. Additionally, the company actively engages in the development of complex Active Pharmaceuticals Ingredients, aiming to offer cost-effective and superior-quality API’s. The commitment to innovation and excellence remains at the forefront of Avisa Pharma’s mission.